Back to KROS

JACOBS LEVY EQUITY MANAGEMENT, INC → KROS

JACOBS LEVY EQUITY MANAGEMENT, INC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$5.3M
Q3 2026
Peak value
$15.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$15.6M
Q1 2026$7.8M
Q2 2026$6.5M
Q3 2026$5.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$5.3M461.1K——
Q2 2026$6.5M605.4K——
Q1 2026$7.8M706.1K——
Q4 2025$15.6M768.4K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other JACOBS LEVY EQUITY MANAGEMENT, INC positions

NVDA

NVIDIA CORPORATION

$2.1B
NVDA

NVIDIA CORPORATION

$1.8B
NVDA

NVIDIA CORPORATION

$1.6B
GOOGN

ALPHABET INC

$1.5B
NVDA

NVIDIA CORPORATION

$1.4B
GOOGN

ALPHABET INC

$1.4B
AAPL

APPLE INC

$1.3B
AAPL

APPLE INC

$1.2B